Because the University doing the study has no idea
Post# of 148277
Quote:
However, a once-quarterly at home formulation would dramatically increase patient adherence. To this end we will develop a novel formulation of long-acting Leronlimab that can be administered at home in a low volume able to provide coverage for three months.
https://reporter.nih.gov/project-details/10064937